279 related articles for article (PubMed ID: 30199308)
1. Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?
Carmina E; Lobo RA
J Womens Health (Larchmt); 2018 Nov; 27(11):1385-1388. PubMed ID: 30199308
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.
Guan C; Zahid S; Minhas AS; Ouyang P; Vaught A; Baker VL; Michos ED
Fertil Steril; 2022 May; 117(5):924-935. PubMed ID: 35512976
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
[TBL] [Abstract][Full Text] [Related]
5. Changes in the PCOS phenotype with age.
Hsu MI
Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
[TBL] [Abstract][Full Text] [Related]
6. Reproductive health, obesity, and cardiometabolic risk factors among Samoan women.
Maredia H; Hawley NL; Lambert-Messerlian G; Fidow U; Reupena MS; Naseri T; McGarvey ST
Am J Hum Biol; 2018 May; 30(3):e23106. PubMed ID: 29663637
[TBL] [Abstract][Full Text] [Related]
7. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
8. Subclinical cardiovascular disease and polycystic ovary syndrome.
Gomez JMD; VanHise K; Stachenfeld N; Chan JL; Merz NB; Shufelt C
Fertil Steril; 2022 May; 117(5):912-923. PubMed ID: 35512975
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome and metabolic syndrome.
Ali AT
Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
[TBL] [Abstract][Full Text] [Related]
10. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention.
Osibogun O; Ogunmoroti O; Michos ED
Trends Cardiovasc Med; 2020 Oct; 30(7):399-404. PubMed ID: 31519403
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
Lo JC; Feigenbaum SL; Yang J; Pressman AR; Selby JV; Go AS
J Clin Endocrinol Metab; 2006 Apr; 91(4):1357-63. PubMed ID: 16434451
[TBL] [Abstract][Full Text] [Related]
13. Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease.
Dubey P; Reddy S; Sharma K; Johnson S; Hardy G; Dwivedi AK
Curr Cardiol Rep; 2024 Jun; 26(6):483-495. PubMed ID: 38568339
[TBL] [Abstract][Full Text] [Related]
14. Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome.
Lentscher JA; Decherney AH
Clin Obstet Gynecol; 2021 Mar; 64(1):3-11. PubMed ID: 32701517
[TBL] [Abstract][Full Text] [Related]
15. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of polycystic ovarian syndrome in adolescents.
Nicandri KF; Hoeger K
Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):497-504. PubMed ID: 23076041
[TBL] [Abstract][Full Text] [Related]
17. Polycystic Ovary Syndrome among Obese Adolescents.
Ybarra M; Franco RR; Cominato L; Sampaio RB; Sucena da Rocha SM; Damiani D
Gynecol Endocrinol; 2018 Jan; 34(1):45-48. PubMed ID: 28758509
[TBL] [Abstract][Full Text] [Related]
18. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls--a 2 year follow-up study.
Nair MK; Pappachan P; Balakrishnan S; Leena ML; George B; Russell PS
Indian J Pediatr; 2012 Jan; 79 Suppl 1():S69-73. PubMed ID: 21769526
[TBL] [Abstract][Full Text] [Related]
19. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
[TBL] [Abstract][Full Text] [Related]
20. [Body composition and polycystic ovary syndrome].
Zabuliene L; Tutkuviene J
Medicina (Kaunas); 2010; 46(2):142-57. PubMed ID: 20440089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
